Skip to Main Content
Practices & Industries

Ambulatory Surgery Center Transactions

Print Version

Our Ambulatory Surgery Center (ASC) Transactions Team combines deep industry knowledge with practical, business-focused solutions derived from experience with many dozens of ASC transactions across the country.

Overview


Our Ambulatory Surgery Center (ASC) Transactions Team combines deep industry knowledge with practical, business-focused solutions derived from experience with many dozens of ASC transactions across the country. We deliver tailored business-oriented strategies that align with each ASC's objectives and market dynamics.

Our Experience in ASC Transactions

Baker Donelson has extensive experience advising ASCs of all sizes nationwide on a vast array of strategic transactions to position them for success, including:

  • Sales, divestitures, and consolidations with national management companies, investors, and private equity-backed platforms
  • Acquisitions of ASCs by buyers of all sizes, including large ASC networks and chains
  • Mergers and consolidations with hospital systems and joint venture partners
  • Syndication with physicians and other investors
  • ASC and office-based labs (OBL) development/formation among physicians in different specialties (and investors)

Regulatory Compliance

Our team has decades of experience navigating the complex regulatory requirements that affect ASCs and play a critical role in due diligence for these transactions. Our attorneys provide guidance on:

  • Anti-Kickback Statute compliance and similar state laws, including financial relationship structuring, referral arrangements, ASC safe harbor provisions, and compliant buy-ins and redemptions
  • Certificate of need and licensing regulations for each state
  • Accreditation and survey issues
  • Medicare and Medicaid regulations, including billing, documentation, provider enrollment, change of ownership, and reimbursement requirements
  • State health care transaction review laws, which can elongate the sign-to-close period and introduce regulatory risk into the dealmaking process
  • HIPAA compliance, including business associate agreements, cybersecurity policies, and breach notification requirements
  • Federal and state employment and benefits laws, including overtime laws, family leave laws, anti-discrimination laws (disability/Americans with Disabilities Act, racial, age, gender, etc.), and ERISA/benefit plan compliance

Results may vary depending on your particular facts and legal circumstances. Some of these matters were handled by a current Baker Donelson professional while associated with a prior firm.

  • Represented an ambulatory surgery center specializing in orthopedic surgical procedures located in southern California in its majority sale and joint venture with a non-profit health system.

  • Represented an interventional pain management practice in Nevada in its partial sale to and joint venture with a national operator of surgical facilities.

  • Advised a cardiology group located in Texas in the sale of their practice and ASC to a large Texas health system.

  • Represented a cardiology practice and its ASCs and office-based labs in connection with a sale to a regional health system in the Midwest.

  • Represented a large orthopedic surgery group and ambulatory surgery center in Pennsylvania in an affiliation with a large health system.

  • Represented a physician-owned ambulatory surgery center operator with three facilities in the Mountain West region in its joint venture with a national management company.

  • Representing an orthopedic-focused ASC in the Southwest in its sale to regional health system.

  • Advised a gastroenterology focused ASC in New York in its sale of a majority ownership interest in the company to a national ASC operator.

  • Represented ASCs owned by ophthalmologists in sales to a private equity-backed platform.

  • Represented a gastroenterology group and surgery center in a transaction with an Ohio health system.

  • Represented regional ASC operator and management company in its acquisition 10 ASCs in New York and New Jersey over a period of several years.

  • Advised a national operator of outpatient vascular centers in its divestiture of a multi-specialty surgery center focused on interventional nephrology, cardiovascular and gastroenterology procedures located in the Northeast.

  • Represented a midwestern-based health system in the formation of a joint venture with a national leader in ASC management services and simultaneous acquisition of a majority ownership interest in a multi-specialty surgery center in Idaho.

  • Represented an ASC operator in its acquisition of 3 ASCs in South Florida.

  • Represented a large health system in its joint venture with a national ASC management company in the contribution of or development of a dozen ASCs which in the Northeast.

  • Represented a private investor group in its acquisition of a national ASC management company from its publicly traded parent company.

  • Guided a regional ASC operator in its development of five (5) de novo ASCs in New York and New Jersey.

  • Represented a private equity-backed neurosurgery group-owned ASC in its sale to a publicly traded physician practice and urgent care company.

  • Advised a healthcare system partnering with a national management company on several joint ventured ASCs in the Mid Atlantic.

  • Represented physician group in a joint venture with a commercial developer to build a de novo ASC in New Jersey.

  • Counseled various outpatient surgery centers on equity syndications to physicians and sales of majority ownership to hospitals, health systems, and nationally recognized ASC management businesses.

  • Assisted a national ambulatory surgery platform in a change of control which impacted the licensure of over twenty surgery centers located in New Jersey.

  • Represented a hospital joint venturing with a regional leader specializing in the development and management of freestanding endoscopy ASCs.

  • Represented a hospital joint venturing with a national organization providing management and development support for ASCs and physicians in the development and licensure of two de-novo ASCs.

  • "Returns, Risks, and Rewards: Structuring Strategic Transactions for ASCs and Surgery Groups," 29th Annual Becker's ASCS Conference (October 2023)
  • "Strategic Transactions for Spine, Orthopedic, and Pain Management Groups," Spine, Orthopedic + Pain Management-Driven ASC Conference (June 2023)
  • "Strategic Partnerships with Private Equity Firms: What ASCs Need to Know," 28th Annual Becker's ASC Review (October 2022)

Email Disclaimer

NOTICE: The mailing of this email is not intended to create, and receipt of it does not constitute an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.
Cancel Accept